Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2023-10-01
2028-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aimed questions to answer:
1. whether dEMG control will improve balance and postural stability of amputees,
2. whether dEMG control will lead to more natural neuromuscular control and coordination, 3) whether dEMG control will reduce cognitive processes.
Participants will go through PT guided training on using dEMG controlled prosthetic ankles and are evaluated for their capability on functional tasks.
The results will be compared with a comparison group, which goes through the same training but with their everyday passive prostheses on balance capability, neuromuscular coordination, and cognitive load during locomotion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-time Motion Capture and Visual Feedback for Amputation Gait Training
NCT07049198
The Effect of Alternative Prosthetic Alignments on Sit-to-Stand Proficiency in Transtibial Amputees
NCT04657614
Radiological and Clinical Measures as Predictors of Dynamic Postural Control Deficits in Chronic Ankle Instability
NCT07051018
Role of Sensory Deficits on Sensorimotor Control in Athletes With Chronic Ankle Instability
NCT06118879
Effect of Eight-week Concurrent Training on Functional Capacity in Patients With Unilateral Transtibial Amputation
NCT04165434
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Number of Lab Visits: 15 visits. Clinicians may recommend skipping some of the visits or tasks based on clinical evaluation and status of the participants.
* Length of Lab Visit: three hours maximum
1. First visit: the purpose of the first visit is to conduct consent and conduct measurements to decide walking speed and ABC (amputee balance confidence) score.
2. Second visit: this visit is to ensure that the amputees' own socket system can be integrated into the powered prosthetic leg and validate the effectiveness of the EMG interface.
3. Third and fourth visits: baseline evaluation with powered prosthesis and passive prosthesis. Each participant will finish the two visits. One of the visits is dedicated to their own passive prosthesis and the other visit is for the powered prosthesis. The sequence of the evaluation is randomized. The tasks conducted in the two visits are generally identical. The only difference is that one of the visits uses the participants' everyday prosthetic foot and the other uses the powered prosthetic ankle
4. Fifth and sixth visits: these visits are dedicated to have the participants trained to regain muscle coordination, which is critical to use the powered prosthetic ankle. All the participants will go through these trainings. Based on whether the participants are selected as the powered prosthetic group (Group A) or the passive group (Group B), the participants will finish this training with the powered prosthetic leg or a passive prosthetic leg.
5. Seven - eleventh visits: These visits are designed to give participants needed training, so participants are able to integrate the action of the powered prosthetic ankle with their full body motion for various tasks. To ensure that contribution of the training procedure to the performance changes are considered, all the participants will go through the training with the prostheses aligned with their group.
6. Twelfth-thirteenth visit (duplicate of Third and fourth visit). These visits are used to evaluate the impact of the training program on the performance of the participants to conduct tasks which are not included in the training procedure. Each participant will conduct the task with both passive and powered prosthetic legs on different days.
7. Fourteenth-fifteenth visits (duplicate of Third and fourth visit). These visits are used to understand the long term effects of the training program on the participants. These visits will be conducted three months after the 13th visits.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dEMG group
Patients go through the training procedure with the direct EMG controlled powered prosthetic ankle.
direct EMG controlled prosthetic ankle
Patients are trained to use the powered prosthetic ankles
PT guided prosthetic training
Amputees are trained to use prosthetic ankles
Passive group
Patients go through the training procedure with their own passive prosthetic ankles
PT guided prosthetic training
Amputees are trained to use prosthetic ankles
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
direct EMG controlled prosthetic ankle
Patients are trained to use the powered prosthetic ankles
PT guided prosthetic training
Amputees are trained to use prosthetic ankles
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* unilateral bower limb amputee
* K-level 2 or higher (who are frequent prosthesis users and may benefit from the proposed prosthesis training and use of dEMG controlled powered prosthesis)
* Amputation occurred over 2 years ago
* At least 1 year of experience using their prosthetic leg
* Has used the current socket for at least 6 months without a significant skin issue or major modification
* Are willing to come to NC State University's Centennial Campus to participate in research and be photographed while doing research activities
Exclusion Criteria
* Cannot perform functional ambulation in the community on a daily basis without assistive devices
* Cognitive or visual impairment that affects the participant's ability to provide informed consent or to follow simple instructions during the experiments
* Congenital amputees
* Amputees who use powered prosthetic ankles
* Weight more than 300lbs
* Pregnant Person
* Allergic to latex, which is often contained in medical tapes.
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of North Carolina, Chapel Hill
OTHER
North Carolina State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
He Huang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
He Huang, PhD
Role: PRINCIPAL_INVESTIGATOR
NC State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
North Carolina State University
Raleigh, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
26076
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.